Current aspects of the spectrum of acute heart failure syndromes in a real‐life setting: the OFICA study

D Logeart, R Isnard, M Resche‐Rigon… - European journal of …, 2013 - Wiley Online Library
Aims To improve knowledge of epidemiological data, management, and clinical outcome of
acute heart failure (AHF) in a real‐life setting in France. Methods and results We conducted …

Iron deficiency: an emerging therapeutic target in heart failure

A Cohen-Solal, C Leclercq, G Deray, S Lasocki… - Heart, 2014 - heart.bmj.com
In patients with heart failure, iron deficiency is frequent but overlooked, with a prevalence of
30%–50%. Since it contributes to cardiac and peripheral muscle dysfunction, iron deficiency …

Sleep apnea syndromes and cardiovascular disease

JP Bounhoure, M Galinier, A Didier… - Bulletin de l'Academie …, 2005 - europepmc.org
Sleep-disordered breathing is very common and is associated with an increased risk of
cardiovascular disease, cardiac arrhythmia and stroke. There are two types of sleep apnea …

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study

P Jourdain, G Jondeau, F Funck, P Gueffet… - Journal of the American …, 2007 - jacc.org
Objectives: The aim of this multicenter study was to evaluate the prognostic impact of a
therapeutic strategy using plasma brain natriuretic peptide (BNP) levels. Background: The …

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised …

R Wachter, M Senni, J Belohlavek… - European journal of …, 2019 - Wiley Online Library
Aims To assess tolerability and optimal time point for initiation of sacubitril/valsartan in
patients stabilised after acute heart failure (AHF). Methods and results TRANSITION was a …

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study

G Montalescot, B Pitt, E Lopez de Sa… - European heart …, 2014 - academic.oup.com
Aims We aimed to assess the impact of eplerenone on cardiovascular (CV) outcomes in
STEMI without known heart failure, when initiated within 24 h of symptom onset. Methods …

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode

G Jondeau, Y Neuder, JC Eicher… - European heart …, 2009 - academic.oup.com
Aims Whether or not beta-blocker therapy should be stopped during acutely decompensated
heart failure (ADHF) is unsure. Methods and results In a randomized, controlled, open …

Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial

J Roncalli, F Mouquet, C Piot, JN Trochu… - European heart …, 2011 - academic.oup.com
Aims Intracoronary administration of autologous bone marrow cells (BMCs) leads to a
modest improvement in cardiac function, but the effect on myocardial viability is unknown …

Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial

SD Solomon, AR Rizkala, MP Lefkowitz… - Circulation: Heart …, 2018 - Am Heart Assoc
Background: To describe the baseline characteristics of patients with heart failure and
preserved left ventricular ejection fraction enrolled in the PARAGON-HF trial (Prospective …

Telemonitoring versus standard care in heart failure: a randomised multicentre trial

M Galinier, F Roubille, P Berdague… - European journal of …, 2020 - Wiley Online Library
Aims The aim was to assess the effect of a telemonitoring programme vs. standard care (SC)
in preventing all‐cause deaths or unplanned hospitalisations in heart failure (HF) at 18 …